Delivery Order SPE2DB22D1202-SPE2DB24FUKT2
Award Date 12/19/23
Potential Completion Date 12/20/23
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $1,168.15 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of Trokendi XR 50 mg capsules, a pharmaceutical product, to support DLA Troop Support Medical programs and facilities. AmerisourceBergen Drug Corp, as a prime contractor, has a history of providing pharmaceuticals,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,689.54 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count). This firm fixed-price, competitively awarded contract with no set-aside designation was executed on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a firm fixed price delivery order for $2,004.30 from the Defense Logistics Agency (DLA) Troop Support Medical program. The order is to supply 4562729710 Trokendi XR 100mg capsules, 30 count, with performance at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by November 7, 2023. No set-aside designation was used for this award issued against an indefinite delivery contract held by...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The $1,076.16 contract is for the delivery of Trokendi XR 25 mg capsules to support military treatment programs and medical facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the...
- This delivery order, valued at $4,785.57, awards AmerisourceBergen Drug Corp the supply of Trokendi XR 200 mg capsules (30-count units) under a Firm Fixed Price contract with the Defense Logistics Agency (DLA). The contract, awarded on October 21, 2025, with completion due by October 22, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a non-set-aside, competitively awarded delivery order issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $7,207.55 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count) under a firm fixed-price arrangement. The contract, which was competitively awarded without set-aside designation, is scheduled for completion by September 24, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a $751.98 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg Trokendi XR capsules. Under this order, Amerisourcebergen will deliver 30 capsules to a location in Conshohocken, Pennsylvania by July 28, 2023 to fulfill requirements on behalf of the Department of Defense. As a top pharmaceutical supplier, Amerisourcebergen routinely supports the DLA's medical materiel needs through existing indefinite delivery vehicle contracts. No...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the supply of Trokendi XR 200 mg capsules, a specialty pharmaceutical product. The firm fixed price delivery order has a potential value of $1,253.08 and a completion date of March 5, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp serves as a prime...
- The Defense Logistics Agency awarded a $4,622.34 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Trokendi XR 200 mg capsules (30-count units). This non-set-aside contract was competitively awarded and is scheduled for completion by August 21, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Trokendi XR 50 mg capsules (30-count) with a ceiling value of $2,995.93. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 8, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUKT2Delivery Order
This is a $1,084.82 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for the supply of Trokendi XR 100 mg capsules to support DLA Troop Support Medical programs. AmerisourceBergen Drug Corp, through its Corporate Office division, regularly provides pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of Defense. This delivery order does not have a set-aside designation and is scheduled for completion by December 20, 2023. AmerisourceBergen Corporation is the parent company of the awardee, AmerisourceBergen Drug Corp.
Generated 3/20/24, 3:47 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/19/23 |